Pregnancy Testing in Patients with Etonogestrel Implant
You do not routinely need a urine hCG test to rule out pregnancy in a patient with an etonogestrel implant, but you should obtain one if the patient's bleeding pattern abruptly changes to amenorrhea or if you cannot be "reasonably certain" she is not pregnant.
When to Test for Pregnancy
The CDC guidelines provide clear criteria for when pregnancy testing is indicated in implant users 1:
Test if:
- Abrupt change in bleeding pattern to amenorrhea - If a woman's regular bleeding pattern suddenly changes to amenorrhea, consider ruling out pregnancy if clinically indicated 1
- Cannot establish "reasonable certainty" of non-pregnancy - Use the pregnancy checklist criteria below
Do NOT routinely test if:
- The implant has been correctly in place
- No concerning symptoms are present
- Amenorrhea is part of the expected bleeding pattern (22% of etonogestrel implant users experience amenorrhea normally) 1
"Reasonably Certain" Criteria
You can be reasonably certain a woman is NOT pregnant if she has no symptoms/signs of pregnancy AND meets at least one of these criteria 1, 2:
- ≤7 days after start of normal menses
- Has not had sexual intercourse since last normal menses
- Has been correctly and consistently using a reliable contraceptive method (this includes the implant)
- ≤7 days after spontaneous or induced abortion
- Within 4 weeks postpartum
- Fully/nearly fully breastfeeding, amenorrheic, and <6 months postpartum
The pregnancy checklist has a negative predictive value of 99-100% 1, meaning it effectively rules out pregnancy when criteria are met.
Key Clinical Context
Why Implants Are Different from IUDs
The evidence distinguishes between implants and IUDs regarding pregnancy risk management. For contraceptive methods other than IUDs (including implants), the benefits of continuing the method likely exceed any risk, even when uncertain about pregnancy status 1. Studies show no increased risk for adverse outcomes, congenital anomalies, or neonatal/infant death among infants exposed in utero to hormonal contraceptives like those in implants 1.
This contrasts sharply with IUDs, where pregnancy carries higher risks of spontaneous abortion, septic abortion, preterm delivery, and chorioamnionitis 1.
Implant Effectiveness
The etonogestrel implant is highly effective: fewer than 1 woman out of 100 becomes pregnant in the first year with typical use 1. However, rare pregnancies can occur, including in years 3-4 of use 3.
Important Caveats
Limitations of Urine hCG Testing
Be aware that urine pregnancy tests have significant limitations 1:
- Sensitivity varies widely (20-25 mIU/mL claimed, but detection rates vary) 1
- May require 11 additional days past missed menses to detect 100% of pregnancies 1
- Cannot detect pregnancy from recent sexual intercourse 1
- May remain positive for weeks after abortion or delivery 1
- Some devices detect hyperglycosylated hCG (the predominant early pregnancy form) poorly 4
- False negatives can occur at low hCG concentrations 5, and rare cases of ectopic pregnancy with negative urine tests have been reported 6
When Uncertainty Exists
If you cannot establish reasonable certainty of non-pregnancy but clinical suspicion is low, you can continue the implant and perform follow-up pregnancy testing in 2-4 weeks 1. The risks of not using contraception generally outweigh the minimal risks of continuing hormonal contraception during early unrecognized pregnancy.
Clinical Algorithm
- Assess "reasonable certainty" criteria - Does she meet any of the criteria listed above?
- If YES and no concerning symptoms → No pregnancy test needed
- If NO or abrupt change to amenorrhea → Obtain urine hCG
- If uncertain but low suspicion → Consider continuing implant with follow-up testing in 2-4 weeks
- If positive pregnancy test → Counsel on options; implant exposure carries minimal fetal risk based on available evidence
The bottom line: The implant itself, when correctly in place, serves as evidence of "reasonable certainty" that pregnancy is unlikely, making routine pregnancy testing unnecessary in most clinical scenarios 1, 2.